{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T16:52:48Z","timestamp":1776271968990,"version":"3.50.1"},"reference-count":239,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Cardiovasc. Transl. Res."],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s12265-026-10768-6","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T14:27:25Z","timestamp":1776263245000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["New Advances in the Mechanisms and Therapeutic Strategies of Gut Microbiota in Regulating Glycolipid Metabolism to Combat Atherosclerosis"],"prefix":"10.1007","volume":"19","author":[{"given":"Hui","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pihong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naizhi","family":"Geng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,15]]},"reference":[{"key":"10768_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/biom8030080","author":"Y Zhu","year":"2018","unstructured":"Zhu Y, et al. Research progress on the relationship between atherosclerosis and inflammation. Biomolecules. 2018. https:\/\/doi.org\/10.3390\/biom8030080.","journal-title":"Biomolecules"},{"key":"10768_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ejphar.2017.05.010","volume":"816","author":"B Emini Veseli","year":"2017","unstructured":"Emini Veseli B, et al. Animal models of atherosclerosis. Eur J Pharmacol. 2017;816:3\u201313.","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"10768_CR3","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41572-019-0106-z","volume":"5","author":"P Libby","year":"2019","unstructured":"Libby P, et al. Atherosclerosis. Nat Rev Dis Primers. 2019;5(1):56.","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"10768_CR4","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/pin.13202","volume":"72","author":"J Fan","year":"2022","unstructured":"Fan J, Watanabe T. Atherosclerosis: known and unknown. Pathol Int. 2022;72(3):151\u201360.","journal-title":"Pathol Int"},{"issue":"1","key":"10768_CR5","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1186\/s12885-022-09604-2","volume":"22","author":"X Zeng","year":"2022","unstructured":"Zeng X, et al. Cardiovascular risk factors and breast cancer incidence in a large middle-aged cohort study. BMC Cancer. 2022;22(1):534.","journal-title":"BMC Cancer"},{"issue":"2","key":"10768_CR6","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1161\/CIRCRESAHA.120.315890","volume":"128","author":"M Nayor","year":"2021","unstructured":"Nayor M, Brown KJ, Vasan RS. The molecular basis of predicting atherosclerotic cardiovascular disease risk. Circ Res. 2021;128(2):287\u2013303.","journal-title":"Circ Res"},{"issue":"5","key":"10768_CR7","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/MOL.0000000000000330","volume":"27","author":"J Boren","year":"2016","unstructured":"Boren J, Williams KJ. The central role of arterial retention of cholesterol-rich apolipoprotein-B-containing lipoproteins in the pathogenesis of atherosclerosis: a triumph of simplicity. Curr Opin Lipidol. 2016;27(5):473\u201383.","journal-title":"Curr Opin Lipidol"},{"issue":"Suppl 1(Suppl 1","key":"10768_CR8","doi-asserted-by":"publisher","first-page":"4592","DOI":"10.1073\/pnas.1011383107","volume":"108","author":"O Koren","year":"2011","unstructured":"Koren O, et al. Human oral, gut, and plaque microbiota in patients with atherosclerosis. Proc Natl Acad Sci U S A. 2011;108(Suppl 1(Suppl 1)):4592\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7341","key":"10768_CR9","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature09922","volume":"472","author":"Z Wang","year":"2011","unstructured":"Wang Z, et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature. 2011;472(7341):57\u201363.","journal-title":"Nature"},{"key":"10768_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/nu9080859","author":"K Lau","year":"2017","unstructured":"Lau K, et al. Bridging the gap between gut microbial dysbiosis and cardiovascular diseases. Nutrients. 2017. https:\/\/doi.org\/10.3390\/nu9080859.","journal-title":"Nutrients"},{"key":"10768_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/nu12102982","author":"BJH Verhaar","year":"2020","unstructured":"Verhaar BJH, et al. Gut microbiota in hypertension and atherosclerosis: a review. Nutrients. 2020. https:\/\/doi.org\/10.3390\/nu12102982.","journal-title":"Nutrients"},{"issue":"50","key":"10768_CR12","doi-asserted-by":"publisher","first-page":"e23730","DOI":"10.1097\/MD.0000000000023730","volume":"99","author":"L Huang","year":"2020","unstructured":"Huang L, et al. Regulatory effect of traditional Chinese medicine on gut microbiota in patients with atherosclerosis: A protocol for systematic review and meta-analysis. Medicine (Baltimore). 2020;99(50):e23730.","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"10768_CR13","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.31083\/j.rcm2204142","volume":"22","author":"ZC Wang","year":"2021","unstructured":"Wang ZC, et al. A narrative review of plant and herbal medicines for delaying diabetic atherosclerosis: an update and future perspectives. Rev Cardiovasc Med. 2021;22(4):1361\u201381.","journal-title":"Rev Cardiovasc Med"},{"issue":"17","key":"10768_CR14","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1093\/eurheartj\/ehv043","volume":"36","author":"ES Stroes","year":"2015","unstructured":"Stroes ES, et al. Statin-associated muscle symptoms: impact on statin therapy-European atherosclerosis society consensus panel statement on assessment. Aetiol Manag Eur Heart J. 2015;36(17):1012\u201322.","journal-title":"Aetiol Manag Eur Heart J"},{"key":"10768_CR15","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/3910116","volume":"2022","author":"Z Huang","year":"2022","unstructured":"Huang Z, et al. Ameliorating effect on glycolipid metabolism of spirulina functional formulation combination from traditional Chinese medicine. Oxid Med Cell Longev. 2022;2022:3910116.","journal-title":"Oxid Med Cell Longev"},{"issue":"3","key":"10768_CR16","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1124\/pharmrev.120.000096","volume":"73","author":"S Xu","year":"2021","unstructured":"Xu S, et al. Endothelial dysfunction in atherosclerotic cardiovascular diseases and beyond: from mechanism to pharmacotherapies. Pharmacol Rev. 2021;73(3):924\u201367.","journal-title":"Pharmacol Rev"},{"key":"10768_CR17","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.atherosclerosis.2018.08.039","volume":"277","author":"C Wang","year":"2018","unstructured":"Wang C, et al. Treatment of atherosclerosis by traditional Chinese medicine: questions and quandaries. Atherosclerosis. 2018;277:136\u201344.","journal-title":"Atherosclerosis"},{"key":"10768_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci13081226","author":"T Benameur","year":"2023","unstructured":"Benameur T, et al. Emerging paradigms in inflammatory disease management: exploring bioactive compounds and the gut microbiota. Brain Sci. 2023. https:\/\/doi.org\/10.3390\/brainsci13081226.","journal-title":"Brain Sci"},{"issue":"1","key":"10768_CR19","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/s41467-017-00900-1","volume":"8","author":"Z Jie","year":"2017","unstructured":"Jie Z, et al. The gut microbiome in atherosclerotic cardiovascular disease. Nat Commun. 2017;8(1):845.","journal-title":"Nat Commun"},{"issue":"5","key":"10768_CR20","doi-asserted-by":"publisher","first-page":"e37104","DOI":"10.1097\/MD.0000000000037104","volume":"103","author":"H Huang","year":"2024","unstructured":"Huang H, et al. Prospect of research on anti-atherosclerosis effect of main components of traditional Chinese medicine Yiqi Huoxue Huatan recipe through gut microbiota: a review. Medicine (Baltimore). 2024;103(5):e37104.","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10768_CR21","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s43556-022-00091-2","volume":"3","author":"L Wang","year":"2022","unstructured":"Wang L, et al. The role of the gut microbiota in health and cardiovascular diseases. Mol Biomed. 2022;3(1):30.","journal-title":"Mol Biomed"},{"key":"10768_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21051835","author":"A Poznyak","year":"2020","unstructured":"Poznyak A, et al. The diabetes mellitus-atherosclerosis connection: the role of lipid and glucose metabolism and chronic inflammation. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21051835.","journal-title":"Int J Mol Sci"},{"key":"10768_CR23","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/2958920","volume":"2019","author":"S Di","year":"2019","unstructured":"Di S, et al. The intervention effect of traditional Chinese medicine on the intestinal flora and its metabolites in glycolipid metabolic disorders. Evid Based Complement Alternat Med. 2019;2019:2958920.","journal-title":"Evid Based Complement Alternat Med"},{"key":"10768_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2020.145066","volume":"763","author":"JR Zhang","year":"2020","unstructured":"Zhang JR, Sun HJ. Roles of circular RNAs in diabetic complications: from molecular mechanisms to therapeutic potential. Gene. 2020;763:145066.","journal-title":"Gene"},{"issue":"25","key":"10768_CR25","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1056\/NEJMoa052187","volume":"353","author":"DM Nathan","year":"2005","unstructured":"Nathan DM, et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005;353(25):2643\u201353.","journal-title":"N Engl J Med"},{"key":"10768_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.952398","volume":"13","author":"L Wang","year":"2022","unstructured":"Wang L, et al. Glucose metabolism and glycosylation link the gut microbiota to autoimmune diseases. Front Immunol. 2022;13:952398.","journal-title":"Front Immunol"},{"issue":"1","key":"10768_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-019-0550-9","volume":"26","author":"SC Su","year":"2019","unstructured":"Su SC. Cilostazol inhibits hyperglucose-induced vascular smooth muscle cell dysfunction by modulating the RAGE\/ERK\/NF-kappaB signaling pathways. J Biomed Sci. 2019;26(1):68.","journal-title":"J Biomed Sci"},{"issue":"1","key":"10768_CR28","doi-asserted-by":"publisher","first-page":"27","DOI":"10.5551\/jat.RV17014","volume":"25","author":"N Katakami","year":"2018","unstructured":"Katakami N. Mechanism of development of atherosclerosis and cardiovascular disease in diabetes mellitus. J Atheroscler Thromb. 2018;25(1):27\u201339.","journal-title":"J Atheroscler Thromb"},{"issue":"9","key":"10768_CR29","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1038\/s41419-022-05274-x","volume":"13","author":"ZC Wang","year":"2022","unstructured":"Wang ZC, et al. A dual Keap1 and p47(phox) inhibitor Ginsenoside Rb1 ameliorates high glucose\/ox-LDL-induced endothelial cell injury and atherosclerosis. Cell Death Dis. 2022;13(9):824.","journal-title":"Cell Death Dis"},{"issue":"5","key":"10768_CR30","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.cmet.2010.03.013","volume":"11","author":"C Rask-Madsen","year":"2010","unstructured":"Rask-Madsen C, et al. Loss of insulin signaling in vascular endothelial cells accelerates atherosclerosis in apolipoprotein E null mice. Cell Metab. 2010;11(5):379\u201389.","journal-title":"Cell Metab"},{"issue":"1","key":"10768_CR31","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2024.2307581","volume":"16","author":"J Zhang","year":"2024","unstructured":"Zhang J. Microbial stars: shedding light on gut microbes\u2019 role in insulin resistance and innovative diabetes therapies. Gut Microbes. 2024;16(1):2307581.","journal-title":"Gut Microbes"},{"issue":"1","key":"10768_CR32","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/1462-2920.13589","volume":"19","author":"P Louis","year":"2017","unstructured":"Louis P, Flint HJ. Formation of propionate and butyrate by the human colonic microbiota. Environ Microbiol. 2017;19(1):29\u201341.","journal-title":"Environ Microbiol"},{"issue":"2","key":"10768_CR33","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s13668-020-00307-3","volume":"9","author":"T Zhu","year":"2020","unstructured":"Zhu T, Goodarzi MO. Metabolites linking the gut microbiome with risk for type 2 diabetes. Curr Nutr Rep. 2020;9(2):83\u201393.","journal-title":"Curr Nutr Rep"},{"issue":"8","key":"10768_CR34","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1136\/gutjnl-2019-318424","volume":"68","author":"ES Chambers","year":"2019","unstructured":"Chambers ES, et al. Dietary supplementation with inulin-propionate ester or inulin improves insulin sensitivity in adults with overweight and obesity with distinct effects on the gut microbiota, plasma metabolome and systemic inflammatory responses: a randomised cross-over trial. Gut. 2019;68(8):1430\u20138.","journal-title":"Gut"},{"issue":"9","key":"10768_CR35","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1007\/s40618-019-01022-9","volume":"42","author":"M Federici","year":"2019","unstructured":"Federici M. Gut microbiome and microbial metabolites: a new system affecting metabolic disorders. J Endocrinol Invest. 2019;42(9):1011\u20138.","journal-title":"J Endocrinol Invest"},{"key":"10768_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23031105","author":"P Portincasa","year":"2022","unstructured":"Portincasa P, et al. Gut microbiota and short chain fatty acids: implications in glucose homeostasis. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23031105.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10768_CR37","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1093\/ajcn\/nqac217","volume":"116","author":"MSA Palmnas-Bedard","year":"2022","unstructured":"Palmnas-Bedard MSA, et al. The human gut microbiota and glucose metabolism: a scoping review of key bacteria and the potential role of SCFAs. Am J Clin Nutr. 2022;116(4):862\u201374.","journal-title":"Am J Clin Nutr"},{"key":"10768_CR38","unstructured":"Venugopal SK, Anoruo M, Jialal I. Biochemistry, low density Lipoprotein, in StatPearls. Treasure Island (FL) ineligible companies. Disclosure: McDamian Anoruo declares no relevant financial relationships with ineligible companies. Disclosure: Ishwarlal Jialal declares no relevant financial relationships with ineligible companies. 2025."},{"issue":"4","key":"10768_CR39","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1161\/CIRCRESAHA.115.306398","volume":"118","author":"K Musunuru","year":"2016","unstructured":"Musunuru K, Kathiresan S. Surprises from genetic analyses of lipid risk factors for atherosclerosis. Circ Res. 2016;118(4):579\u201385.","journal-title":"Circ Res"},{"issue":"23","key":"10768_CR40","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1016\/j.jacc.2009.09.009","volume":"54","author":"P Libby","year":"2009","unstructured":"Libby P, et al. Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol. 2009;54(23):2129\u201338.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10768_CR41","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1161\/CIRCRESAHA.115.307611","volume":"118","author":"W Herrington","year":"2016","unstructured":"Herrington W, et al. Epidemiology of atherosclerosis and the potential to reduce the global burden of atherothrombotic disease. Circ Res. 2016;118(4):535\u201346.","journal-title":"Circ Res"},{"issue":"4","key":"10768_CR42","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/S0092-8674(01)00238-0","volume":"104","author":"CK Glass","year":"2001","unstructured":"Glass CK, Witztum JL. Atherosclerosis. The road ahead. Cell. 2001;104(4):503\u201316.","journal-title":"Cell"},{"issue":"7855","key":"10768_CR43","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41586-021-03392-8","volume":"592","author":"P Libby","year":"2021","unstructured":"Libby P. The changing landscape of atherosclerosis. Nature. 2021;592(7855):524\u201333.","journal-title":"Nature"},{"issue":"10","key":"10768_CR44","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/S0300-8932(09)72385-1","volume":"62","author":"L Badimon","year":"2009","unstructured":"Badimon L, Vilahur G, Padro T. Lipoproteins, platelets and atherothrombosis. Rev Esp Cardiol. 2009;62(10):1161\u201378.","journal-title":"Rev Esp Cardiol"},{"issue":"20","key":"10768_CR45","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1093\/eurheartj\/ehx033","volume":"38","author":"B Gencer","year":"2017","unstructured":"Gencer B, et al. Lipoprotein(a): the revenant. Eur Heart J. 2017;38(20):1553\u201360.","journal-title":"Eur Heart J"},{"issue":"9943","key":"10768_CR46","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/S0140-6736(14)61177-6","volume":"384","author":"BG Nordestgaard","year":"2014","unstructured":"Nordestgaard BG, Varbo A. Triglycerides and cardiovascular disease. Lancet. 2014;384(9943):626\u201335.","journal-title":"Lancet"},{"issue":"9726","key":"10768_CR47","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1016\/S0140-6736(10)60545-4","volume":"375","author":"Triglyceride Coronary Disease Genetics, C.","year":"2010","unstructured":"Triglyceride Coronary Disease Genetics, C., Triglyceride Coronary Disease Genetics Consortium and Emerging Risk Factors Collaboration, et al. Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies. Lancet. 2010;375(9726):1634\u20139.","journal-title":"Lancet"},{"issue":"20","key":"10768_CR48","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1161\/CIR.0b013e3182160726","volume":"123","author":"M Miller","year":"2011","unstructured":"Miller M, et al. Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2011;123(20):2292\u2013333.","journal-title":"Circulation"},{"issue":"4","key":"10768_CR49","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s11154-019-09512-0","volume":"20","author":"M Schoeler","year":"2019","unstructured":"Schoeler M, Caesar R. Dietary lipids, gut microbiota and lipid metabolism. Rev Endocr Metab Disord. 2019;20(4):461\u201372.","journal-title":"Rev Endocr Metab Disord"},{"issue":"4","key":"10768_CR50","doi-asserted-by":"publisher","DOI":"10.1111\/jpi.12524","volume":"65","author":"J Yin","year":"2018","unstructured":"Yin J, et al. Melatonin reprogramming of gut microbiota improves lipid dysmetabolism in high-fat diet-fed mice. J Pineal Res. 2018;65(4):e12524.","journal-title":"J Pineal Res"},{"issue":"11","key":"10768_CR51","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.molmed.2015.09.001","volume":"21","author":"S Fiorucci","year":"2015","unstructured":"Fiorucci S, Distrutti E. Bile acid-activated receptors, intestinal microbiota, and the treatment of metabolic disorders. Trends Mol Med. 2015;21(11):702\u201314.","journal-title":"Trends Mol Med"},{"issue":"7","key":"10768_CR52","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.bbalip.2018.04.005","volume":"1863","author":"Y Wang","year":"2018","unstructured":"Wang Y, Ding WX, Li T. Cholesterol and bile acid-mediated regulation of autophagy in fatty liver diseases and atherosclerosis. Biochim Biophys Acta Mol Cell Biol Lipids. 2018;1863(7):726\u201333.","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"issue":"11","key":"10768_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e21935","volume":"9","author":"J Fu","year":"2023","unstructured":"Fu J, et al. Huangqi chifeng decoction maintains gut microbiota and bile acid homeostasis through FXR signaling to improve atherosclerosis. Heliyon. 2023;9(11):e21935.","journal-title":"Heliyon"},{"issue":"7164","key":"10768_CR54","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1038\/nature06246","volume":"449","author":"R Medzhitov","year":"2007","unstructured":"Medzhitov R. Recognition of microorganisms and activation of the immune response. Nature. 2007;449(7164):819\u201326.","journal-title":"Nature"},{"issue":"8","key":"10768_CR55","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1111\/bph.14933","volume":"177","author":"Y Du","year":"2020","unstructured":"Du Y, et al. Butyrate protects against high-fat diet-induced atherosclerosis via up-regulating ABCA1 expression in apolipoprotein E-deficiency mice. Br J Pharmacol. 2020;177(8):1754\u201372.","journal-title":"Br J Pharmacol"},{"issue":"Pt A","key":"10768_CR56","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ejphar.2015.06.023","volume":"763","author":"JJ Witjes","year":"2015","unstructured":"Witjes JJ, van Raalte DH, Nieuwdorp M. About the gut microbiome as a pharmacological target in atherosclerosis. Eur J Pharmacol. 2015;763(Pt A):75\u20138.","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"10768_CR57","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s12020-018-1605-5","volume":"61","author":"A Pascale","year":"2018","unstructured":"Pascale A, et al. Microbiota and metabolic diseases. Endocrine. 2018;61(3):357\u201371.","journal-title":"Endocrine"},{"issue":"3","key":"10768_CR58","doi-asserted-by":"publisher","first-page":"936","DOI":"10.3892\/ijmm.2020.4674","volume":"46","author":"Y Zhu","year":"2020","unstructured":"Zhu Y, et al. Gut microbiota metabolites as integral mediators in cardiovascular diseases (Review). Int J Mol Med. 2020;46(3):936\u201348.","journal-title":"Int J Mol Med"},{"key":"10768_CR59","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1271001","volume":"14","author":"Y Feng","year":"2023","unstructured":"Feng Y, Xu D. Short-chain fatty acids are potential goalkeepers of atherosclerosis. Front Pharmacol. 2023;14:1271001.","journal-title":"Front Pharmacol"},{"issue":"7","key":"10768_CR60","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.2337\/db14-1213","volume":"64","author":"G den Besten","year":"2015","unstructured":"den Besten G, et al. Short-chain fatty acids protect against high-fat diet-induced obesity via a ppargamma-dependent switch from lipogenesis to fat oxidation. Diabetes. 2015;64(7):2398\u2013408.","journal-title":"Diabetes"},{"issue":"2","key":"10768_CR61","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1111\/dom.12811","volume":"19","author":"A Pingitore","year":"2017","unstructured":"Pingitore A, et al. The diet-derived short chain fatty acid propionate improves beta-cell function in humans and stimulates insulin secretion from human islets in vitro. Diabetes Obes Metab. 2017;19(2):257\u201365.","journal-title":"Diabetes Obes Metab"},{"issue":"6","key":"10768_CR62","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.cell.2016.05.041","volume":"165","author":"A Koh","year":"2016","unstructured":"Koh A, et al. From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites. Cell. 2016;165(6):1332\u201345.","journal-title":"Cell"},{"issue":"2","key":"10768_CR63","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/j.1462-2920.2009.02066.x","volume":"12","author":"P Louis","year":"2010","unstructured":"Louis P, et al. Diversity of human colonic butyrate-producing bacteria revealed by analysis of the butyryl-CoA:acetate CoA-transferase gene. Environ Microbiol. 2010;12(2):304\u201314.","journal-title":"Environ Microbiol"},{"key":"10768_CR64","doi-asserted-by":"publisher","first-page":"533","DOI":"10.3389\/fphar.2018.00533","volume":"9","author":"M Li","year":"2018","unstructured":"Li M, et al. The anti-inflammatory effects of short chain fatty acids on lipopolysaccharide- or tumor necrosis factor alpha-stimulated endothelial cells via activation of GPR41\/43 and inhibition of HDACs. Front Pharmacol. 2018;9:533.","journal-title":"Front Pharmacol"},{"key":"10768_CR65","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1146\/annurev.biochem.72.121801.161712","volume":"72","author":"DW Russell","year":"2003","unstructured":"Russell DW. The enzymes, regulation, and genetics of bile acid synthesis. Annu Rev Biochem. 2003;72:137\u201374.","journal-title":"Annu Rev Biochem"},{"issue":"7","key":"10768_CR66","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1053\/j.gastro.2017.01.055","volume":"152","author":"O Chavez-Talavera","year":"2017","unstructured":"Chavez-Talavera O, et al. Bile acid control of metabolism and inflammation in obesity, type 2 diabetes, dyslipidemia, and nonalcoholic fatty liver disease. Gastroenterology. 2017;152(7):1679-1694 e3.","journal-title":"Gastroenterology"},{"issue":"43","key":"10768_CR67","doi-asserted-by":"publisher","first-page":"6131","DOI":"10.3748\/wjg.v28.i43.6131","volume":"28","author":"ZL Ai","year":"2022","unstructured":"Ai ZL, et al. Salvia miltiorrhiza extract may exert an anti-obesity effect in rats with high-fat diet-induced obesity by modulating gut microbiome and lipid metabolism. World J Gastroenterol. 2022;28(43):6131\u201356.","journal-title":"World J Gastroenterol"},{"issue":"8","key":"10768_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-018-0126-x","volume":"50","author":"C Chelakkot","year":"2018","unstructured":"Chelakkot C, Ghim J, Ryu SH. Mechanisms regulating intestinal barrier integrity and its pathological implications. Exp Mol Med. 2018;50(8):1\u20139.","journal-title":"Exp Mol Med"},{"issue":"4","key":"10768_CR69","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1161\/CIRCRESAHA.120.316242","volume":"127","author":"M Witkowski","year":"2020","unstructured":"Witkowski M, Weeks TL, Hazen SL. Gut microbiota and cardiovascular disease. Circ Res. 2020;127(4):553\u201370.","journal-title":"Circ Res"},{"key":"10768_CR70","doi-asserted-by":"publisher","DOI":"10.3390\/nu13010144","author":"AK Duttaroy","year":"2021","unstructured":"Duttaroy AK. Role of gut microbiota and their metabolites on atherosclerosis, hypertension and human blood platelet function: a review. Nutrients. 2021. https:\/\/doi.org\/10.3390\/nu13010144.","journal-title":"Nutrients"},{"key":"10768_CR71","doi-asserted-by":"publisher","DOI":"10.3390\/ph17020236","author":"S Laudani","year":"2024","unstructured":"Laudani S, et al. Isoflavones effects on vascular and endothelial outcomes: how is the gut microbiota involved? Pharmaceuticals (Basel). 2024. https:\/\/doi.org\/10.3390\/ph17020236.","journal-title":"Pharmaceuticals (Basel)"},{"key":"10768_CR72","doi-asserted-by":"publisher","first-page":"864600","DOI":"10.3389\/fcvm.2022.864600","volume":"9","author":"L Jing","year":"2022","unstructured":"Jing L, et al. Targeting trimethylamine n-oxide: a new therapeutic strategy for alleviating atherosclerosis. Front Cardiovasc Med. 2022;9:864600.","journal-title":"Front Cardiovasc Med"},{"issue":"5","key":"10768_CR73","first-page":"516","volume":"23","author":"MS Hakhamaneshi","year":"2021","unstructured":"Hakhamaneshi MS, et al. Toll-like receptor 4: a macrophage cell surface receptor is activated by trimethylamine-N-oxide. Cell Journal (Yakhteh). 2021;23(5):516\u201322.","journal-title":"Cell Journal (Yakhteh)"},{"key":"10768_CR74","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.936677","volume":"13","author":"X Shi","year":"2022","unstructured":"Shi X, et al. Inhibiting vascular smooth muscle cell proliferation mediated by osteopontin via regulating gut microbial lipopolysaccharide: a novel mechanism for paeonol in atherosclerosis treatment. Front Pharmacol. 2022;13:936677.","journal-title":"Front Pharmacol"},{"issue":"11","key":"10768_CR75","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/nri2653","volume":"9","author":"JR Turner","year":"2009","unstructured":"Turner JR. Intestinal mucosal barrier function in health and disease. Nat Rev Immunol. 2009;9(11):799\u2013809.","journal-title":"Nat Rev Immunol"},{"issue":"36","key":"10768_CR76","doi-asserted-by":"publisher","first-page":"e2304294","DOI":"10.1002\/advs.202304294","volume":"10","author":"J Cheng","year":"2023","unstructured":"Cheng J, et al. Nanomedicine for diagnosis and treatment of atherosclerosis. Adv Sci (Weinh). 2023;10(36):e2304294.","journal-title":"Adv Sci (Weinh)"},{"key":"10768_CR77","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22083850","author":"DJ Medina-Leyte","year":"2021","unstructured":"Medina-Leyte DJ, et al. Endothelial dysfunction, inflammation and coronary artery disease: potential biomarkers and promising therapeutical approaches. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms22083850.","journal-title":"Int J Mol Sci"},{"key":"10768_CR78","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-11-117","volume":"11","author":"J Frostegard","year":"2013","unstructured":"Frostegard J. Immunity, atherosclerosis and cardiovascular disease. BMC Med. 2013;11:117.","journal-title":"BMC Med"},{"issue":"3","key":"10768_CR79","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s10456-023-09876-7","volume":"26","author":"AC Dudley","year":"2023","unstructured":"Dudley AC, Griffioen AW. Pathological angiogenesis: mechanisms and therapeutic strategies. Angiogenesis. 2023;26(3):313\u201347.","journal-title":"Angiogenesis"},{"key":"10768_CR80","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20215293","author":"B Herrero-Fernandez","year":"2019","unstructured":"Herrero-Fernandez B, et al. Immunobiology of atherosclerosis: a complex net of interactions. Int J Mol Sci. 2019. https:\/\/doi.org\/10.3390\/ijms20215293.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10768_CR81","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1161\/CIRCRESAHA.115.306301","volume":"118","author":"MA Gimbrone Jr.","year":"2016","unstructured":"Gimbrone MA Jr., Garcia-Cardena G. Endothelial cell dysfunction and the pathobiology of atherosclerosis. Circ Res. 2016;118(4):620\u201336.","journal-title":"Circ Res"},{"issue":"1","key":"10768_CR82","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.carpath.2012.06.006","volume":"22","author":"MA Gimbrone Jr.","year":"2013","unstructured":"Gimbrone MA Jr., Garcia-Cardena G. Vascular endothelium, hemodynamics, and the pathobiology of atherosclerosis. Cardiovasc Pathol. 2013;22(1):9\u201315.","journal-title":"Cardiovasc Pathol"},{"key":"10768_CR83","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.freeradbiomed.2019.07.029","volume":"143","author":"Y Cheng","year":"2019","unstructured":"Cheng Y, et al. Alcohol promotes waste clearance in the CNS via brain vascular reactivity. Free Radic Biol Med. 2019;143:115\u201326.","journal-title":"Free Radic Biol Med"},{"issue":"Pt 2","key":"10768_CR84","doi-asserted-by":"publisher","first-page":"131868","DOI":"10.1016\/j.ijbiomac.2024.131868","volume":"268","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, et al. Asprosin aggravates atherosclerosis via regulating the phenotype transformation of vascular smooth muscle cells. Int J Biol Macromol. 2024;268(Pt 2):131868.","journal-title":"Int J Biol Macromol"},{"issue":"4","key":"10768_CR85","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1161\/CIRCRESAHA.116.308334","volume":"118","author":"P Libby","year":"2016","unstructured":"Libby P, Bornfeldt KE, Tall AR. Atherosclerosis: successes, surprises, and future challenges. Circ Res. 2016;118(4):531\u20134.","journal-title":"Circ Res"},{"issue":"11","key":"10768_CR86","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1093\/cvr\/cvab046","volume":"117","author":"MOJ Grootaert","year":"2021","unstructured":"Grootaert MOJ, Bennett MR. Vascular smooth muscle cells in atherosclerosis: time for a re-assessment. Cardiovasc Res. 2021;117(11):2326\u201339.","journal-title":"Cardiovasc Res"},{"issue":"2","key":"10768_CR87","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1093\/cvr\/cvs115","volume":"95","author":"D Gomez","year":"2012","unstructured":"Gomez D, Owens GK. Smooth muscle cell phenotypic switching in atherosclerosis. Cardiovasc Res. 2012;95(2):156\u201364.","journal-title":"Cardiovasc Res"},{"issue":"4","key":"10768_CR88","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1161\/CIRCRESAHA.115.306361","volume":"118","author":"MR Bennett","year":"2016","unstructured":"Bennett MR, Sinha S, Owens GK. Vascular smooth muscle cells in atherosclerosis. Circ Res. 2016;118(4):692\u2013702.","journal-title":"Circ Res"},{"issue":"2","key":"10768_CR89","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1161\/CIRCULATIONAHA.111.061986","volume":"125","author":"CS Robbins","year":"2012","unstructured":"Robbins CS, et al. Extramedullary hematopoiesis generates Ly-6C(high) monocytes that infiltrate atherosclerotic lesions. Circulation. 2012;125(2):364\u201374.","journal-title":"Circulation"},{"issue":"5","key":"10768_CR90","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.cmet.2011.07.015","volume":"14","author":"KE Bornfeldt","year":"2011","unstructured":"Bornfeldt KE, Tabas I. Insulin resistance, hyperglycemia, and atherosclerosis. Cell Metab. 2011;14(5):575\u201385.","journal-title":"Cell Metab"},{"key":"10768_CR91","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21082992","author":"NV Mushenkova","year":"2020","unstructured":"Mushenkova NV, et al. Current advances in the diagnostic imaging of atherosclerosis: insights into the pathophysiology of vulnerable plaque. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21082992.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10768_CR92","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/s41569-023-00957-0","volume":"21","author":"GRY De Meyer","year":"2024","unstructured":"De Meyer GRY, et al. Programmed death of macrophages in atherosclerosis: mechanisms and therapeutic targets. Nat Rev Cardiol. 2024;21(5):312\u201325.","journal-title":"Nat Rev Cardiol"},{"issue":"13","key":"10768_CR93","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1161\/CIRCULATIONAHA.108.806158","volume":"119","author":"EL Gautier","year":"2009","unstructured":"Gautier EL, et al. Macrophage apoptosis exerts divergent effects on atherogenesis as a function of lesion stage. Circulation. 2009;119(13):1795\u2013804.","journal-title":"Circulation"},{"issue":"16","key":"10768_CR94","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1056\/NEJMra043430","volume":"352","author":"GK Hansson","year":"2005","unstructured":"Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352(16):1685\u201395.","journal-title":"N Engl J Med"},{"issue":"4","key":"10768_CR95","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/s41569-019-0265-3","volume":"17","author":"T Kuznetsova","year":"2020","unstructured":"Kuznetsova T, et al. Transcriptional and epigenetic regulation of macrophages in atherosclerosis. Nat Rev Cardiol. 2020;17(4):216\u201328.","journal-title":"Nat Rev Cardiol"},{"issue":"2 Suppl 1","key":"10768_CR96","doi-asserted-by":"publisher","first-page":"S150","DOI":"10.1016\/j.dsx.2016.01.024","volume":"10","author":"M Mazidi","year":"2016","unstructured":"Mazidi M, et al. Gut microbiome and metabolic syndrome. Diabetes Metab Syndr. 2016;10(2 Suppl 1):S150-7.","journal-title":"Diabetes Metab Syndr"},{"key":"10768_CR97","first-page":"4095789","volume":"2018","author":"O Castaner","year":"2018","unstructured":"Castaner O, et al. The gut microbiome profile in obesity: a systematic review. Int J Endocrinol. 2018;2018:4095789.","journal-title":"Int J Endocrinol"},{"issue":"1","key":"10768_CR98","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41577-019-0198-4","volume":"20","author":"H Tilg","year":"2020","unstructured":"Tilg H, et al. The intestinal microbiota fuelling metabolic inflammation. Nat Rev Immunol. 2020;20(1):40\u201354.","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"10768_CR99","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.ajpath.2012.10.014","volume":"182","author":"S Guo","year":"2013","unstructured":"Guo S, et al. Lipopolysaccharide causes an increase in intestinal tight junction permeability in vitro and in vivo by inducing enterocyte membrane expression and localization of TLR-4 and CD14. Am J Pathol. 2013;182(2):375\u201387.","journal-title":"Am J Pathol"},{"issue":"6","key":"10768_CR100","doi-asserted-by":"publisher","first-page":"437","DOI":"10.4093\/dmj.2014.38.6.437","volume":"38","author":"KY Hur","year":"2014","unstructured":"Hur KY. Is GDF15 a novel biomarker to predict the development of prediabetes or diabetes? Diabetes Metab J. 2014;38(6):437\u20138.","journal-title":"Diabetes Metab J"},{"issue":"1","key":"10768_CR101","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s12967-023-03993-z","volume":"21","author":"M Zhang","year":"2023","unstructured":"Zhang M, et al. Matrine alleviates depressive-like behaviors via modulating microbiota-gut-brain axis in CUMS-induced mice. J Transl Med. 2023;21(1):145.","journal-title":"J Transl Med"},{"issue":"4","key":"10768_CR102","doi-asserted-by":"publisher","first-page":"401","DOI":"10.2174\/1389201015666140711114450","volume":"15","author":"N Xia","year":"2014","unstructured":"Xia N, Forstermann U, Li H. Resveratrol as a gene regulator in the vasculature. Curr Pharm Biotechnol. 2014;15(4):401\u20138.","journal-title":"Curr Pharm Biotechnol"},{"key":"10768_CR103","doi-asserted-by":"publisher","DOI":"10.3390\/nu11030497","author":"E Caro-Gomez","year":"2019","unstructured":"Caro-Gomez E, et al. Green coffee extract improves cardiometabolic parameters and modulates gut microbiota in high-fat-diet-fed ApoE(-\/-) mice. Nutrients. 2019. https:\/\/doi.org\/10.3390\/nu11030497.","journal-title":"Nutrients"},{"key":"10768_CR104","doi-asserted-by":"publisher","first-page":"7092151","DOI":"10.1155\/2019\/7092151","volume":"2019","author":"S Steven","year":"2019","unstructured":"Steven S, et al. Vascular inflammation and oxidative stress: major triggers for cardiovascular disease. Oxid Med Cell Longev. 2019;2019:7092151.","journal-title":"Oxid Med Cell Longev"},{"key":"10768_CR105","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18061321","author":"AE Achari","year":"2017","unstructured":"Achari AE, Jain SK. Adiponectin, a therapeutic target for obesity, diabetes, and endothelial dysfunction. Int J Mol Sci. 2017. https:\/\/doi.org\/10.3390\/ijms18061321.","journal-title":"Int J Mol Sci"},{"key":"10768_CR106","doi-asserted-by":"publisher","DOI":"10.3390\/cells13010001","author":"AE Cullen","year":"2023","unstructured":"Cullen AE, et al. The duality of adiponectin: the role of sex in atherosclerosis. Cells. 2023. https:\/\/doi.org\/10.3390\/cells13010001.","journal-title":"Cells"},{"key":"10768_CR107","doi-asserted-by":"publisher","DOI":"10.3390\/nu12010119","author":"AWC Man","year":"2020","unstructured":"Man AWC, Li H, Xia N. Resveratrol and the interaction between gut microbiota and arterial remodelling. Nutrients. 2020. https:\/\/doi.org\/10.3390\/nu12010119.","journal-title":"Nutrients"},{"issue":"3","key":"10768_CR108","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/ni.2001","volume":"12","author":"GK Hansson","year":"2011","unstructured":"Hansson GK, Hermansson A. The immune system in atherosclerosis. Nat Immunol. 2011;12(3):204\u201312.","journal-title":"Nat Immunol"},{"issue":"10","key":"10768_CR109","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1093\/eurheartj\/ehs411","volume":"34","author":"E Falk","year":"2013","unstructured":"Falk E, et al. Update on acute coronary syndromes: the pathologists\u2019 view. Eur Heart J. 2013;34(10):719\u201328.","journal-title":"Eur Heart J"},{"key":"10768_CR110","doi-asserted-by":"publisher","DOI":"10.3390\/nu11030578","author":"T De Bruyne","year":"2019","unstructured":"De Bruyne T, et al. Dietary polyphenols targeting arterial stiffness: interplay of contributing mechanisms and gut microbiome-related metabolism. Nutrients. 2019. https:\/\/doi.org\/10.3390\/nu11030578.","journal-title":"Nutrients"},{"issue":"7","key":"10768_CR111","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1080\/17474086.2019.1627191","volume":"12","author":"H Formes","year":"2019","unstructured":"Formes H, Reinhardt C. The gut microbiota - a modulator of endothelial cell function and a contributing environmental factor to arterial thrombosis. Expert Rev Hematol. 2019;12(7):541\u20139.","journal-title":"Expert Rev Hematol"},{"issue":"1","key":"10768_CR112","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1161\/HYPERTENSIONAHA.120.14759","volume":"76","author":"VE Brunt","year":"2020","unstructured":"Brunt VE, et al. Trimethylamine-N-oxide promotes age-related vascular oxidative stress and endothelial dysfunction in mice and healthy humans. Hypertension. 2020;76(1):101\u201312.","journal-title":"Hypertension"},{"key":"10768_CR113","doi-asserted-by":"publisher","DOI":"10.3390\/toxins13030223","author":"J Fryc","year":"2021","unstructured":"Fryc J, Naumnik B. Thrombolome and its emerging role in chronic kidney diseases. Toxins (Basel). 2021. https:\/\/doi.org\/10.3390\/toxins13030223.","journal-title":"Toxins (Basel)"},{"issue":"8","key":"10768_CR114","doi-asserted-by":"publisher","first-page":"e011569","DOI":"10.1161\/CIRCHEARTFAILURE.124.011569","volume":"17","author":"WHW Tang","year":"2024","unstructured":"Tang WHW, et al. Trimethylamine n-oxide and related gut microbe-derived metabolites and incident heart failure development in community-based populations. Circ Heart Fail. 2024;17(8):e011569.","journal-title":"Circ Heart Fail"},{"key":"10768_CR115","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.002816","author":"V Senthong","year":"2016","unstructured":"Senthong V, et al. Intestinal microbiota-generated metabolite trimethylamine-n-oxide and 5-year mortality risk in stable coronary artery disease: the contributory role of intestinal microbiota in a courage-like patient cohort. J Am Heart Assoc. 2016. https:\/\/doi.org\/10.1161\/JAHA.115.002816.","journal-title":"J Am Heart Assoc"},{"issue":"5","key":"10768_CR116","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1016\/j.jvs.2017.09.029","volume":"68","author":"CA Cason","year":"2018","unstructured":"Cason CA, et al. Plasma microbiome-modulated indole- and phenyl-derived metabolites associate with advanced atherosclerosis and postoperative outcomes. J Vasc Surg. 2018;68(5):1552-1562 e7.","journal-title":"J Vasc Surg"},{"issue":"1","key":"10768_CR117","doi-asserted-by":"publisher","first-page":"14963","DOI":"10.1038\/s41598-021-93803-7","volume":"11","author":"V Senthong","year":"2021","unstructured":"Senthong V, et al. Gut microbiota-generated metabolite, trimethylamine-N-oxide, and subclinical myocardial damage: a multicenter study from Thailand. Sci Rep. 2021;11(1):14963.","journal-title":"Sci Rep"},{"issue":"2","key":"10768_CR118","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/nrcardio.2016.183","volume":"14","author":"AL Jonsson","year":"2017","unstructured":"Jonsson AL, Backhed F. Role of gut microbiota in atherosclerosis. Nat Rev Cardiol. 2017;14(2):79\u201387.","journal-title":"Nat Rev Cardiol"},{"issue":"5","key":"10768_CR119","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-020-01041-5","volume":"22","author":"C Chi","year":"2020","unstructured":"Chi C, et al. Effects of probiotics on patients with hypertension: a systematic review and meta-analysis. Curr Hypertens Rep. 2020;22(5):34.","journal-title":"Curr Hypertens Rep"},{"issue":"1","key":"10768_CR120","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-018-0441-4","volume":"6","author":"X Zhou","year":"2018","unstructured":"Zhou X, et al. Gut-dependent microbial translocation induces inflammation and cardiovascular events after ST-elevation myocardial infarction. Microbiome. 2018;6(1):66.","journal-title":"Microbiome"},{"issue":"5","key":"10768_CR121","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1080\/10408398.2011.596955","volume":"54","author":"G Grosso","year":"2014","unstructured":"Grosso G, et al. Mediterranean diet and cardiovascular risk factors: a systematic review. Crit Rev Food Sci Nutr. 2014;54(5):593\u2013610.","journal-title":"Crit Rev Food Sci Nutr"},{"key":"10768_CR122","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.990476","volume":"13","author":"B Xie","year":"2022","unstructured":"Xie B, et al. Ginsenoside Rc ameliorated atherosclerosis via regulating gut microbiota and fecal metabolites. Front Pharmacol. 2022;13:990476.","journal-title":"Front Pharmacol"},{"issue":"1","key":"10768_CR123","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jgr.2020.07.002","volume":"45","author":"Q Xue","year":"2021","unstructured":"Xue Q, et al. Functional roles and mechanisms of ginsenosides from Panax ginseng in atherosclerosis. J Ginseng Res. 2021;45(1):22\u201331.","journal-title":"J Ginseng Res"},{"key":"10768_CR124","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00727","volume":"8","author":"L Qiao","year":"2017","unstructured":"Qiao L, et al. Ginsenoside Rb1 enhances atherosclerotic plaque stability by improving autophagy and lipid metabolism in macrophage foam cells. Front Pharmacol. 2017;8:727.","journal-title":"Front Pharmacol"},{"issue":"12","key":"10768_CR125","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1111\/bph.16320","volume":"181","author":"Y Wang","year":"2024","unstructured":"Wang Y, et al. Ginsenosides retard atherogenesis via remodelling host-microbiome metabolic homeostasis. Br J Pharmacol. 2024;181(12):1768\u201392.","journal-title":"Br J Pharmacol"},{"issue":"18","key":"10768_CR126","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000033748","volume":"102","author":"X Xuan","year":"2023","unstructured":"Xuan X, et al. Research progress of traditional Chinese medicine (TCM) in targeting inflammation and lipid metabolism disorder for arteriosclerosis intervention: a review. Medicine (Baltimore). 2023;102(18):e33748.","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"10768_CR127","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1080\/09637480500081738","volume":"56","author":"HG Rodrigues","year":"2005","unstructured":"Rodrigues HG, et al. Antioxidant effect of saponin: potential action of a soybean flavonoid on glucose tolerance and risk factors for atherosclerosis. Int J Food Sci Nutr. 2005;56(2):79\u201385.","journal-title":"Int J Food Sci Nutr"},{"issue":"8","key":"10768_CR128","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1016\/j.bmcl.2011.02.071","volume":"21","author":"LY Zha","year":"2011","unstructured":"Zha LY, et al. Anti-inflammatory effect of soyasaponins through suppressing nitric oxide production in LPS-stimulated RAW 264.7 cells by attenuation of NF-kappaB-mediated nitric oxide synthase expression. Bioorg Med Chem Lett. 2011;21(8):2415\u20138.","journal-title":"Bioorg Med Chem Lett"},{"key":"10768_CR129","doi-asserted-by":"publisher","DOI":"10.3390\/nu14234998","author":"H Luo","year":"2022","unstructured":"Luo H, et al. Advances in the bioactivities of phytochemical saponins in the prevention and treatment of atherosclerosis. Nutrients. 2022. https:\/\/doi.org\/10.3390\/nu14234998.","journal-title":"Nutrients"},{"key":"10768_CR130","doi-asserted-by":"crossref","unstructured":"Li J, et al. Artemisinins target GABA(A) receptor signaling and impair alpha cell identity. Cell. 2017;168(1\u20132):86\u2013100 e15","DOI":"10.1016\/j.cell.2016.11.010"},{"key":"10768_CR131","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173408","volume":"884","author":"LH He","year":"2020","unstructured":"He LH, et al. Artesunate inhibits atherosclerosis by upregulating vascular smooth muscle cells-derived LPL expression via the KLF2\/NRF2\/TCF7L2 pathway. Eur J Pharmacol. 2020;884:173408.","journal-title":"Eur J Pharmacol"},{"key":"10768_CR132","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.108413","volume":"102","author":"X Wang","year":"2022","unstructured":"Wang X, Du H, Li X. Artesunate attenuates atherosclerosis by inhibiting macrophage M1-like polarization and improving metabolism. Int Immunopharmacol. 2022;102:108413.","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"10768_CR133","doi-asserted-by":"publisher","first-page":"707","DOI":"10.3892\/mmr.2020.11165","volume":"22","author":"Y Liu","year":"2020","unstructured":"Liu Y, et al. Effects of dihydroartemisinin on the gut microbiome of mice. Mol Med Rep. 2020;22(2):707\u201314.","journal-title":"Mol Med Rep"},{"issue":"1","key":"10768_CR134","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1080\/1061186X.2019.1616296","volume":"28","author":"Y Jiang","year":"2020","unstructured":"Jiang Y, et al. Artemisinin alleviates atherosclerotic lesion by reducing macrophage inflammation via regulation of AMPK\/NF-kappaB\/NLRP3 inflammasomes pathway. J Drug Target. 2020;28(1):70\u20139.","journal-title":"J Drug Target"},{"key":"10768_CR135","doi-asserted-by":"publisher","first-page":"1123700","DOI":"10.3389\/fphar.2023.1123700","volume":"14","author":"Y Cen","year":"2023","unstructured":"Cen Y, et al. Anti-malarial artesunate ameliorates atherosclerosis by modulating arterial inflammatory responses via inhibiting the NF-kappaB-NLRP3 inflammasome pathway. Front Pharmacol. 2023;14:1123700.","journal-title":"Front Pharmacol"},{"key":"10768_CR136","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.jconrel.2021.12.021","volume":"341","author":"H Zhou","year":"2022","unstructured":"Zhou H, et al. Artemisinin and procyanidins loaded multifunctional nanocomplexes alleviate atherosclerosis via simultaneously modulating lipid influx and cholesterol efflux. J Control Release. 2022;341:828\u201343.","journal-title":"J Control Release"},{"issue":"4","key":"10768_CR137","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1124\/pr.118.017178","volume":"71","author":"D Wang","year":"2019","unstructured":"Wang D, et al. Targeting foam cell formation in atherosclerosis: therapeutic potential of natural products. Pharmacol Rev. 2019;71(4):596\u2013670.","journal-title":"Pharmacol Rev"},{"key":"10768_CR138","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26134036","author":"L Singh","year":"2021","unstructured":"Singh L, et al. Curcumin as a natural remedy for atherosclerosis: a pharmacological review. Molecules. 2021. https:\/\/doi.org\/10.3390\/molecules26134036.","journal-title":"Molecules"},{"issue":"1\u20132","key":"10768_CR139","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0047-6374(00)00169-X","volume":"119","author":"A Ramirez-Bosca","year":"2000","unstructured":"Ramirez-Bosca A, et al. An hydroalcoholic extract of curcuma longa lowers the apo B\/apo A ratio. Implications for atherogenesis prevention. Mech Ageing Dev. 2000;119(1\u20132):41\u20137.","journal-title":"Mech Ageing Dev"},{"issue":"1","key":"10768_CR140","doi-asserted-by":"publisher","DOI":"10.1080\/16546628.2017.1361780","volume":"61","author":"L Shen","year":"2017","unstructured":"Shen L, Liu L, Ji HF. Regulative effects of curcumin spice administration on gut microbiota and its pharmacological implications. Food Nutr Res. 2017;61(1):1361780.","journal-title":"Food Nutr Res"},{"issue":"4","key":"10768_CR141","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.bbrc.2015.10.051","volume":"467","author":"FY Chen","year":"2015","unstructured":"Chen FY, et al. Curcumin retunes cholesterol transport homeostasis and inflammation response in M1 macrophage to prevent atherosclerosis. Biochem Biophys Res Commun. 2015;467(4):872\u20138.","journal-title":"Biochem Biophys Res Commun"},{"key":"10768_CR142","doi-asserted-by":"publisher","first-page":"4713","DOI":"10.2147\/DDDT.S327238","volume":"15","author":"BS Alotaibi","year":"2021","unstructured":"Alotaibi BS, et al. Therapeutic effects and safe uses of plant-derived polyphenolic compounds in cardiovascular diseases: a review. Drug Des Devel Ther. 2021;15:4713\u201332.","journal-title":"Drug Des Devel Ther"},{"key":"10768_CR143","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21031055","author":"R Pluta","year":"2020","unstructured":"Pluta R, Januszewski S, Ulamek-Koziol M. Mutual two-way interactions of curcumin and gut microbiota. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21031055.","journal-title":"Int J Mol Sci"},{"key":"10768_CR144","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecoenv.2022.114057","volume":"244","author":"J Zhang","year":"2022","unstructured":"Zhang J, Ou C, Chen M. Curcumin attenuates cadmium-induced atherosclerosis by regulating trimethylamine-N-oxide synthesis and macrophage polarization through remodeling the gut microbiota. Ecotoxicol Environ Saf. 2022;244:114057.","journal-title":"Ecotoxicol Environ Saf"},{"key":"10768_CR145","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173090","volume":"877","author":"C Yunna","year":"2020","unstructured":"Yunna C, et al. Macrophage M1\/M2 polarization. Eur J Pharmacol. 2020;877:173090.","journal-title":"Eur J Pharmacol"},{"key":"10768_CR146","doi-asserted-by":"publisher","first-page":"709629","DOI":"10.3389\/fphar.2021.709629","volume":"12","author":"S Yang","year":"2021","unstructured":"Yang S, et al. Multi-pharmacology of berberine in atherosclerosis and metabolic diseases: potential contribution of gut microbiota. Front Pharmacol. 2021;12:709629.","journal-title":"Front Pharmacol"},{"issue":"S2","key":"10768_CR147","first-page":"20","volume":"26","author":"Q Hou","year":"2020","unstructured":"Hou Q, et al. Berberine: a traditional natural product with novel biological activities. Altern Ther Health Med. 2020;26(S2):20\u20137.","journal-title":"Altern Ther Health Med"},{"issue":"3","key":"10768_CR148","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1002\/jsfa.12242","volume":"103","author":"Y Chen","year":"2023","unstructured":"Chen Y, et al. Berberine alleviates intestinal barrier dysfunction in glucolipid metabolism disorder hamsters by modulating gut microbiota and gut-microbiota-related tryptophan metabolites. J Sci Food Agric. 2023;103(3):1464\u201373.","journal-title":"J Sci Food Agric"},{"issue":"5","key":"10768_CR149","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1002\/ptr.5587","volume":"30","author":"Y Dong","year":"2016","unstructured":"Dong Y, et al. Metabolomics study of type 2 diabetes mellitus and the antidiabetic effect of berberine in zucker diabetic fatty rats using Uplc-ESI-Hdms. Phytother Res. 2016;30(5):823\u20138.","journal-title":"Phytother Res"},{"issue":"2","key":"10768_CR150","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.atherosclerosis.2015.09.032","volume":"243","author":"A Pirillo","year":"2015","unstructured":"Pirillo A, Catapano AL. Berberine, a plant alkaloid with lipid- and glucose-lowering properties: from in vitro evidence to clinical studies. Atherosclerosis. 2015;243(2):449\u201361.","journal-title":"Atherosclerosis"},{"issue":"6","key":"10768_CR151","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/j.bcp.2005.12.028","volume":"71","author":"KW Liang","year":"2006","unstructured":"Liang KW, et al. Berberine suppresses MEK\/ERK-dependent Egr-1 signaling pathway and inhibits vascular smooth muscle cell regrowth after in vitro mechanical injury. Biochem Pharmacol. 2006;71(6):806\u201317.","journal-title":"Biochem Pharmacol"},{"key":"10768_CR152","doi-asserted-by":"publisher","first-page":"8683404","DOI":"10.1155\/2020\/8683404","volume":"2020","author":"W Tan","year":"2020","unstructured":"Tan W, et al. improvement of endothelial dysfunction of berberine in atherosclerotic mice and mechanism exploring through TMT-based proteomics. Oxid Med Cell Longev. 2020;2020:8683404.","journal-title":"Oxid Med Cell Longev"},{"key":"10768_CR153","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00223","volume":"11","author":"M Wu","year":"2020","unstructured":"Wu M, et al. Effect of berberine on atherosclerosis and gut microbiota modulation and their correlation in high-fat diet-fed ApoE-\/- mice. Front Pharmacol. 2020;11:223.","journal-title":"Front Pharmacol"},{"issue":"1","key":"10768_CR154","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41392-022-01027-6","volume":"7","author":"SR Ma","year":"2022","unstructured":"Ma SR, et al. Berberine treats atherosclerosis via a vitamine-like effect down-regulating Choline-TMA-TMAO production pathway in gut microbiota. Signal Transduct Target Ther. 2022;7(1):207.","journal-title":"Signal Transduct Target Ther"},{"key":"10768_CR155","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/112_2020_42","volume":"178","author":"A Fatahian","year":"2020","unstructured":"Fatahian A, et al. Promising anti-atherosclerotic effect of berberine: evidence from in vitro, in vivo, and clinical studies. Rev Physiol Biochem Pharmacol. 2020;178:83\u2013110.","journal-title":"Rev Physiol Biochem Pharmacol"},{"issue":"6","key":"10768_CR156","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1080\/19390211.2018.1472714","volume":"16","author":"P Sarkar","year":"2019","unstructured":"Sarkar P, et al. Effects of resveratrol and mangiferin on PPARgamma and FALDH gene expressions in adipose tissue of streptozotocin-nicotinamide-induced diabetes in rats. J Diet Suppl. 2019;16(6):659\u201375.","journal-title":"J Diet Suppl"},{"key":"10768_CR157","doi-asserted-by":"publisher","first-page":"5820245","DOI":"10.1155\/2020\/5820245","volume":"2020","author":"X Luo","year":"2020","unstructured":"Luo X, et al. Drp-1 as potential therapeutic target for lipopolysaccharide-induced vascular hyperpermeability. Oxid Med Cell Longev. 2020;2020:5820245.","journal-title":"Oxid Med Cell Longev"},{"key":"10768_CR158","doi-asserted-by":"publisher","first-page":"540","DOI":"10.12659\/MSM.910996","volume":"25","author":"X Huo","year":"2019","unstructured":"Huo X, et al. Resveratrol effects on a diabetic rat model with coronary heart disease. Med Sci Monit. 2019;25:540\u20136.","journal-title":"Med Sci Monit"},{"issue":"8","key":"10768_CR159","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.2337\/db05-1188","volume":"55","author":"M Zang","year":"2006","unstructured":"Zang M, et al. Polyphenols stimulate AMP-activated protein kinase, lower lipids, and inhibit accelerated atherosclerosis in diabetic LDL receptor-deficient mice. Diabetes. 2006;55(8):2180\u201391.","journal-title":"Diabetes"},{"issue":"2","key":"10768_CR160","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.02210-15","volume":"7","author":"ML Chen","year":"2016","unstructured":"Chen ML, et al. Resveratrol attenuates Trimethylamine-N-Oxide (TMAO)-induced atherosclerosis by regulating tmao synthesis and bile acid metabolism via remodeling of the gut microbiota. MBio. 2016;7(2):e02210-e2215.","journal-title":"MBio"},{"issue":"6","key":"10768_CR161","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/j.bbadis.2014.10.016","volume":"1852","author":"BN Zordoky","year":"2015","unstructured":"Zordoky BN, Robertson IM, Dyck JR. Preclinical and clinical evidence for the role of resveratrol in the treatment of cardiovascular diseases. Biochim Biophys Acta. 2015;1852(6):1155\u201377.","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"10768_CR162","doi-asserted-by":"publisher","first-page":"4313","DOI":"10.1111\/jcmm.14323","volume":"23","author":"G Ye","year":"2019","unstructured":"Ye G, et al. Resveratrol inhibits lipid accumulation in the intestine of atherosclerotic mice and macrophages. J Cell Mol Med. 2019;23(6):4313\u201325.","journal-title":"J Cell Mol Med"},{"key":"10768_CR163","doi-asserted-by":"publisher","DOI":"10.3390\/nu15051212","author":"AM Centner","year":"2023","unstructured":"Centner AM, et al. The role of phytochemicals and gut microbiome in atherosclerosis in preclinical mouse models. Nutrients. 2023. https:\/\/doi.org\/10.3390\/nu15051212.","journal-title":"Nutrients"},{"issue":"1","key":"10768_CR164","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/JLB.3MA0120-325RR","volume":"108","author":"J Wu","year":"2020","unstructured":"Wu J. Paeonol ameliorates murine alcohol liver disease via mycobiota-mediated Dectin-1\/IL-1beta signaling pathway. J Leukoc Biol. 2020;108(1):199\u2013214.","journal-title":"J Leukoc Biol"},{"key":"10768_CR165","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.765482","volume":"12","author":"X Shi","year":"2021","unstructured":"Shi X, et al. Paeonol attenuated vascular fibrosis through regulating Treg\/Th17 balance in a gut microbiota-dependent manner. Front Pharmacol. 2021;12:765482.","journal-title":"Front Pharmacol"},{"key":"10768_CR166","doi-asserted-by":"publisher","first-page":"950337","DOI":"10.3389\/fphar.2022.950337","volume":"13","author":"W Yu","year":"2022","unstructured":"Yu W, et al. A review on therapeutical potential of paeonol in atherosclerosis. Front Pharmacol. 2022;13:950337.","journal-title":"Front Pharmacol"},{"issue":"13","key":"10768_CR167","doi-asserted-by":"publisher","first-page":"3284","DOI":"10.1111\/bph.13120","volume":"172","author":"T Zheng","year":"2015","unstructured":"Zheng T, et al. Salidroside ameliorates insulin resistance through activation of a mitochondria-associated AMPK\/PI3K\/Akt\/GSK3beta pathway. Br J Pharmacol. 2015;172(13):3284\u2013301.","journal-title":"Br J Pharmacol"},{"issue":"4","key":"10768_CR168","doi-asserted-by":"publisher","DOI":"10.31083\/j.rcm2404097","volume":"24","author":"SF Fei","year":"2023","unstructured":"Fei SF, Tong DB, Jia F. Antiatherosclerotic effect and molecular mechanism of salidroside. Rev Cardiovasc Med. 2023;24(4):97.","journal-title":"Rev Cardiovasc Med"},{"key":"10768_CR169","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1400981","volume":"15","author":"SF Fei","year":"2024","unstructured":"Fei SF, Hou C, Jia F. Effects of salidroside on atherosclerosis: potential contribution of gut microbiota. Front Pharmacol. 2024;15:1400981.","journal-title":"Front Pharmacol"},{"key":"10768_CR170","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113746","volume":"156","author":"M Jin","year":"2022","unstructured":"Jin M, et al. Pharmacological effects of salidroside on central nervous system diseases. Biomed Pharmacother. 2022;156:113746.","journal-title":"Biomed Pharmacother"},{"key":"10768_CR171","doi-asserted-by":"publisher","first-page":"3961","DOI":"10.2147\/DDDT.S181939","volume":"12","author":"W Yan","year":"2018","unstructured":"Yan W, et al. Baicalein induces apoptosis and autophagy of breast cancer cells via inhibiting PI3K\/AKT pathway in vivo and vitro. Drug Des Devel Ther. 2018;12:3961\u201372.","journal-title":"Drug Des Devel Ther"},{"issue":"1","key":"10768_CR172","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1007\/s10753-014-0013-0","volume":"38","author":"W Lee","year":"2015","unstructured":"Lee W, Ku SK, Bae JS. Anti-inflammatory effects of baicalin, baicalein, and wogonin in vitro and in vivo. Inflammation. 2015;38(1):110\u201325.","journal-title":"Inflammation"},{"key":"10768_CR173","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/1852330","volume":"2022","author":"L Zhang","year":"2022","unstructured":"Zhang L, et al. Targeting reactive oxygen species in atherosclerosis via Chinese herbal medicines. Oxid Med Cell Longev. 2022;2022:1852330.","journal-title":"Oxid Med Cell Longev"},{"issue":"28","key":"10768_CR174","doi-asserted-by":"publisher","first-page":"42881","DOI":"10.18632\/oncotarget.10263","volume":"7","author":"SH Chan","year":"2016","unstructured":"Chan SH, et al. Baicalein is an available anti-atherosclerotic compound through modulation of nitric oxide-related mechanism under oxLDL exposure. Oncotarget. 2016;7(28):42881\u201391.","journal-title":"Oncotarget"},{"key":"10768_CR175","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.biopha.2016.06.046","volume":"83","author":"XW He","year":"2016","unstructured":"He XW, et al. Anti-atherosclerotic potential of baicalin mediated by promoting cholesterol efflux from macrophages via the PPARgamma-LXRalpha-ABCA1\/ABCG1 pathway. Biomed Pharmacother. 2016;83:257\u201364.","journal-title":"Biomed Pharmacother"},{"key":"10768_CR176","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.925349","volume":"13","author":"P Li","year":"2022","unstructured":"Li P, et al. Multi-omics reveals inhibitory effect of baicalein on non-alcoholic fatty liver disease in mice. Front Pharmacol. 2022;13:925349.","journal-title":"Front Pharmacol"},{"key":"10768_CR177","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1072353","volume":"13","author":"A Blas-Garcia","year":"2022","unstructured":"Blas-Garcia A, Cubero FJ. Editorial: advances in non-alcoholic fatty liver disease therapeutics: pathogenic mechanisms and targets. Front Pharmacol. 2022;13:1072353.","journal-title":"Front Pharmacol"},{"key":"10768_CR178","doi-asserted-by":"publisher","DOI":"10.1242\/bio.060226","author":"B Wang","year":"2023","unstructured":"Wang B, et al. Expression of Concern: Tanshinone IIA suppresses the progression of atherosclerosis by inhibiting the apoptosis of vascular smooth muscle cells and the proliferation and migration of macrophages induced by ox-LDL. Biology Open. 2023. https:\/\/doi.org\/10.1242\/bio.060226.","journal-title":"Biology Open"},{"issue":"6","key":"10768_CR179","first-page":"1082","volume":"44","author":"XU Jian","year":"2024","unstructured":"Jian XU, et al. Chinese patent medicine for atherosclerosis: a systematic review and Meta-analysis of randomized controlled trials. J Tradit Chin Med. 2024;44(6):1082\u201390.","journal-title":"J Tradit Chin Med"},{"issue":"4","key":"10768_CR180","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.3892\/or.2017.5881","volume":"38","author":"J Duan","year":"2017","unstructured":"Duan J, et al. Tetramethylpyrazine suppresses lipid accumulation in macrophages via upregulation of the ATP-binding cassette transporters and downregulation of scavenger receptors. Oncol Rep. 2017;38(4):2267\u201376.","journal-title":"Oncol Rep"},{"issue":"5","key":"10768_CR181","doi-asserted-by":"publisher","first-page":"2642","DOI":"10.26599\/FSHW.2022.9250212","volume":"13","author":"R Yuan","year":"2024","unstructured":"Yuan R, et al. Tetramethylpyrazine and paeoniflorin combination (TMP-PF) alleviates atherosclerosis progress by reducing hyperlipemia and inhibiting plaque angiogenesis via the NR4A1\/VEGFR2 pathway. Food Sci Human Wellness. 2024;13(5):2642\u201352.","journal-title":"Food Sci Human Wellness"},{"issue":"4","key":"10768_CR182","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1002\/biof.2034","volume":"50","author":"M Alkanad","year":"2024","unstructured":"Alkanad M, et al. Bitter yet beneficial: the dual role of dietary alkaloids in managing diabetes and enhancing cognitive function. Biofactors. 2024;50(4):634\u201373.","journal-title":"Biofactors"},{"key":"10768_CR183","doi-asserted-by":"publisher","first-page":"154684","DOI":"10.1016\/j.phymed.2023.154684","volume":"112","author":"X Feng","year":"2023","unstructured":"Feng X, et al. Hydroxysafflor yellow A regulates lymphangiogenesis and inflammation via the inhibition of PI3K on regulating AKT\/mTOR and NF-kappaB pathway in macrophages to reduce atherosclerosis in ApoE-\/- mice. Phytomedicine. 2023;112:154684.","journal-title":"Phytomedicine"},{"key":"10768_CR184","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2021.153694","volume":"91","author":"X Xue","year":"2021","unstructured":"Xue X, et al. Hydroxysafflor yellow A, a natural compound from Carthamus tinctorius L with good effect of alleviating atherosclerosis. Phytomedicine. 2021;91:153694.","journal-title":"Phytomedicine"},{"key":"10768_CR185","doi-asserted-by":"publisher","DOI":"10.1016\/j.matdes.2023.111807","author":"YL Li","year":"2023","unstructured":"Li YL, et al. Hydroxysafflor yellow A-loaded biomimetic liposomes alleviate HHcy-induced atherosclerosis by regulating methylation related autophagy. Mater Des. 2023. https:\/\/doi.org\/10.1016\/j.matdes.2023.111807.","journal-title":"Mater Des"},{"issue":"11","key":"10768_CR186","doi-asserted-by":"publisher","first-page":"8939","DOI":"10.1002\/fsn3.4466","volume":"12","author":"Y Liu","year":"2024","unstructured":"Liu Y, et al. Hydroxysafflor yellow A, a natural food pigment, ameliorates atherosclerosis in ApoE(-\/-) mice by inhibiting the SphK1\/S1P\/S1PR3 pathway. Food Sci Nutr. 2024;12(11):8939\u201355.","journal-title":"Food Sci Nutr"},{"key":"10768_CR187","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2022.867318","volume":"10","author":"XY Sun","year":"2022","unstructured":"Sun XY, et al. Research advances on matrine. Front Chem. 2022;10:867318.","journal-title":"Front Chem"},{"key":"10768_CR188","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.ejmech.2018.10.037","volume":"161","author":"HU Rashid","year":"2019","unstructured":"Rashid HU, et al. Research advances on anticancer activities of matrine and its derivatives: an updated overview. Eur J Med Chem. 2019;161:205\u201338.","journal-title":"Eur J Med Chem"},{"issue":"4","key":"10768_CR189","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1142\/S0192415X24500381","volume":"52","author":"JN Li","year":"2024","unstructured":"Li JN, et al. Multidirectional intervention of Chinese herbal medicine in the prevention and treatment of atherosclerosis: from endothelial protection to immunomodulation. Am J Chin Med. 2024;52(4):925\u201347.","journal-title":"Am J Chin Med"},{"key":"10768_CR190","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2024.1417672","volume":"11","author":"S Chen","year":"2024","unstructured":"Chen S, Wu S, Lin B. The potential therapeutic value of the natural plant compounds matrine and oxymatrine in cardiovascular diseases. Front Cardiovasc Med. 2024;11:1417672.","journal-title":"Front Cardiovasc Med"},{"key":"10768_CR191","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25126613","author":"N Mao","year":"2024","unstructured":"Mao N, et al. Matrine ameliorates DSS-induced colitis by suppressing inflammation, modulating oxidative stress and remodeling the gut microbiota. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms25126613.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"10768_CR192","doi-asserted-by":"publisher","first-page":"13573","DOI":"10.1002\/jcb.28632","volume":"120","author":"H Hou","year":"2019","unstructured":"Hou H, et al. Matrine improves diabetic cardiomyopathy through TGF-beta-induced protein kinase RNA-like endoplasmic reticulum kinase signaling pathway. J Cell Biochem. 2019;120(8):13573\u201382.","journal-title":"J Cell Biochem"},{"key":"10768_CR193","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25235713","author":"SC Yang","year":"2020","unstructured":"Yang SC, et al. Bioactive agent discovery from the natural compounds for the treatment of type 2 diabetes rat model. Molecules. 2020. https:\/\/doi.org\/10.3390\/molecules25235713.","journal-title":"Molecules"},{"issue":"9","key":"10768_CR194","first-page":"1526","volume":"31","author":"H Du","year":"2011","unstructured":"Du H, et al. Effect of early intervention with rhein on islet function in db\/db mice. Nan Fang Yi Ke Da Xue Xue Bao. 2011;31(9):1526\u20139.","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"issue":"11","key":"10768_CR195","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1248\/bpb.31.2154","volume":"31","author":"MS Lee","year":"2008","unstructured":"Lee MS, Sohn CB. Anti-diabetic properties of chrysophanol and its glucoside from rhubarb rhizome. Biol Pharm Bull. 2008;31(11):2154\u20137.","journal-title":"Biol Pharm Bull"},{"issue":"23","key":"10768_CR196","first-page":"6439","volume":"49","author":"CL Wu","year":"2024","unstructured":"Wu CL, et al. Mechanism of chrysophanol in inhibiting ox-LDL-induced macrophage foaminess through NF-kappaB\/HMGB1-PI3K\/Akt\/mTOR pathway. Zhongguo Zhong Yao Za Zhi. 2024;49(23):6439\u201349.","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"issue":"7","key":"10768_CR197","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1002\/ptr.5083","volume":"28","author":"YX Zhou","year":"2014","unstructured":"Zhou YX, Zhang H, Peng C. Puerarin: a review of pharmacological effects. Phytother Res. 2014;28(7):961\u201375.","journal-title":"Phytother Res"},{"key":"10768_CR198","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113472","volume":"153","author":"MK Kwok","year":"2022","unstructured":"Kwok MK, et al. Effect of puerarin supplementation on cardiovascular disease risk factors: a randomized, double-blind, placebo-controlled, 2-way crossover trial. Biomed Pharmacother. 2022;153:113472.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"10768_CR199","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/mnfr.201200511","volume":"57","author":"G Williamson","year":"2013","unstructured":"Williamson G. Possible effects of dietary polyphenols on sugar absorption and digestion. Mol Nutr Food Res. 2013;57(1):48\u201357.","journal-title":"Mol Nutr Food Res"},{"issue":"4","key":"10768_CR200","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1007\/s11154-021-09652-2","volume":"22","author":"M Sharma","year":"2021","unstructured":"Sharma M, Dey CS. AKT ISOFORMS-AS160-GLUT4: The defining axis of insulin resistance. Rev Endocr Metab Disord. 2021;22(4):973\u201386.","journal-title":"Rev Endocr Metab Disord"},{"issue":"1","key":"10768_CR201","doi-asserted-by":"publisher","first-page":"53","DOI":"10.5507\/bp.2013.096","volume":"159","author":"L Bao","year":"2015","unstructured":"Bao L, et al. The anti-atherosclerotic effects of puerarin on induced-atherosclerosis in rabbits. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2015;159(1):53\u20139.","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub"},{"key":"10768_CR202","doi-asserted-by":"crossref","unstructured":"Puerarin alleviates atherosclerosis via the inhibition of Prevotella copri and its trimethylamine production. Gut. 2024;73(12):1934\u20131943.","DOI":"10.1136\/gutjnl-2024-331880"},{"issue":"1","key":"10768_CR203","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/13880209.2022.2099430","volume":"61","author":"J Li","year":"2023","unstructured":"Li J, et al. The effective constituent puerarin, from Pueraria lobata, inhibits the proliferation and inflammation of vascular smooth muscle in atherosclerosis through the miR-29b-3p\/IGF1 pathway. Pharm Biol. 2023;61(1):1\u201311.","journal-title":"Pharm Biol"},{"issue":"4","key":"10768_CR204","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/agm2.12189","volume":"4","author":"L Zhang","year":"2021","unstructured":"Zhang L, Liu L, Wang M. Effects of puerarin on chronic inflammation: focus on the heart, brain, and arteries. Aging Med (Milton). 2021;4(4):317\u201324.","journal-title":"Aging Med (Milton)"},{"issue":"8","key":"10768_CR205","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1161\/CIRCRESAHA.112.266502","volume":"111","author":"D Wang","year":"2012","unstructured":"Wang D, et al. Gut microbiota metabolism of anthocyanin promotes reverse cholesterol transport in mice via repressing miRNA-10b. Circ Res. 2012;111(8):967\u201381.","journal-title":"Circ Res"},{"issue":"24","key":"10768_CR206","doi-asserted-by":"publisher","first-page":"12722","DOI":"10.1021\/jf103427j","volume":"58","author":"D Wang","year":"2010","unstructured":"Wang D, et al. Protocatechuic acid, a metabolite of anthocyanins, inhibits monocyte adhesion and reduces atherosclerosis in apolipoprotein E-deficient mice. J Agric Food Chem. 2010;58(24):12722\u20138.","journal-title":"J Agric Food Chem"},{"issue":"2","key":"10768_CR207","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1039\/D3FO04396G","volume":"15","author":"H Ding","year":"2024","unstructured":"Ding H, et al. Protocatechuic acid alleviates TMAO-aggravated atherosclerosis via mitigating inflammation, regulating lipid metabolism, and reshaping gut microbiota. Food Funct. 2024;15(2):881\u201393.","journal-title":"Food Funct"},{"issue":"15","key":"10768_CR208","doi-asserted-by":"publisher","first-page":"6661","DOI":"10.1021\/jf9015202","volume":"57","author":"CY Lin","year":"2009","unstructured":"Lin CY, et al. Anticoagulatory, antiinflammatory, and antioxidative effects of protocatechuic acid in diabetic mice. J Agric Food Chem. 2009;57(15):6661\u20137.","journal-title":"J Agric Food Chem"},{"issue":"9","key":"10768_CR209","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1292\/jvms.20-0245","volume":"82","author":"L Li","year":"2020","unstructured":"Li L, et al. Effects of protocatechuic acid on ameliorating lipid profiles and cardio-protection against coronary artery disease in high fat and fructose diet fed in rats. J Vet Med Sci. 2020;82(9):1387\u201394.","journal-title":"J Vet Med Sci"},{"issue":"10","key":"10768_CR210","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1016\/j.bbalip.2019.06.005","volume":"1864","author":"X Xu","year":"2019","unstructured":"Xu X, et al. Enhanced cellular cholesterol efflux by naringenin is mediated through inhibiting endoplasmic reticulum stress - ATF6 activity in macrophages. Biochim Biophys Acta Mol Cell Biol Lipids. 2019;1864(10):1472\u201382.","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"10768_CR211","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27249033","author":"X Yu","year":"2022","unstructured":"Yu X, et al. Extraction of naringin from pomelo and its therapeutic potentials against hyperlipidemia. Molecules. 2022. https:\/\/doi.org\/10.3390\/molecules27249033.","journal-title":"Molecules"},{"key":"10768_CR212","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173003","volume":"874","author":"K Wang","year":"2020","unstructured":"Wang K, et al. Naringin inhibits autophagy mediated by PI3K-Akt-mTOR pathway to ameliorate endothelial cell dysfunction induced by high glucose\/high fat stress. Eur J Pharmacol. 2020;874:173003.","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"10768_CR213","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/bcpt.12153","volume":"114","author":"J Chen","year":"2014","unstructured":"Chen J, et al. Naringin inhibits ROS-activated MAPK pathway in high glucose-induced injuries in H9c2 cardiac cells. Basic Clin Pharmacol Toxicol. 2014;114(4):293\u2013304.","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"45","key":"10768_CR214","doi-asserted-by":"publisher","first-page":"12651","DOI":"10.1021\/acs.jafc.0c05800","volume":"68","author":"F Wang","year":"2020","unstructured":"Wang F, et al. Naringin alleviates atherosclerosis in ApoE(-\/-) mice by regulating cholesterol metabolism involved in gut microbiota remodeling. J Agric Food Chem. 2020;68(45):12651\u201360.","journal-title":"J Agric Food Chem"},{"key":"10768_CR215","doi-asserted-by":"publisher","DOI":"10.3390\/nu13113782","author":"VA Uyanga","year":"2021","unstructured":"Uyanga VA, et al. Potential implications of citrulline and quercetin on gut functioning of monogastric animals and humans: a comprehensive review. Nutrients. 2021. https:\/\/doi.org\/10.3390\/nu13113782.","journal-title":"Nutrients"},{"issue":"4","key":"10768_CR216","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1002\/biof.1081","volume":"39","author":"K Kawabata","year":"2013","unstructured":"Kawabata K, et al. Flavonols enhanced production of anti-inflammatory substance(s) by Bifidobacterium adolescentis: prebiotic actions of galangin, quercetin, and fisetin. BioFactors. 2013;39(4):422\u20139.","journal-title":"BioFactors"},{"issue":"27","key":"10768_CR217","doi-asserted-by":"publisher","first-page":"7591","DOI":"10.1080\/10408398.2021.1915745","volume":"62","author":"Y Deng","year":"2022","unstructured":"Deng Y, et al. The role and mechanism of citrus flavonoids in cardiovascular diseases prevention and treatment. Crit Rev Food Sci Nutr. 2022;62(27):7591\u2013614.","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"7","key":"10768_CR218","first-page":"777","volume":"4","author":"M Zahedi","year":"2013","unstructured":"Zahedi M, et al. Does quercetin improve cardiovascular risk factors and inflammatory biomarkers in women with type 2 diabetes: a double-blind randomized controlled clinical trial. Int J Prev Med. 2013;4(7):777\u201385.","journal-title":"Int J Prev Med"},{"issue":"9","key":"10768_CR219","doi-asserted-by":"publisher","first-page":"8003","DOI":"10.1039\/D0FO01439G","volume":"11","author":"T Shi","year":"2020","unstructured":"Shi T, et al. Quercetin improves gut dysbiosis in antibiotic-treated mice. Food Funct. 2020;11(9):8003\u201313.","journal-title":"Food Funct"},{"key":"10768_CR220","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10122001","author":"M Juarez-Fernandez","year":"2021","unstructured":"Juarez-Fernandez M, et al. The synbiotic combination of akkermansia muciniphila and quercetin ameliorates early obesity and nafld through gut microbiota reshaping and bile acid metabolism modulation. Antioxidants. 2021. https:\/\/doi.org\/10.3390\/antiox10122001.","journal-title":"Antioxidants"},{"issue":"11","key":"10768_CR221","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1038\/s41423-021-00726-4","volume":"18","author":"J Liu","year":"2021","unstructured":"Liu J, et al. Dendritic cell migration in inflammation and immunity. Cell Mol Immunol. 2021;18(11):2461\u201371.","journal-title":"Cell Mol Immunol"},{"issue":"16","key":"10768_CR222","doi-asserted-by":"publisher","first-page":"7298","DOI":"10.1039\/D1FO00991E","volume":"12","author":"F Liu","year":"2021","unstructured":"Liu F, et al. Millet shell polyphenols prevent atherosclerosis by protecting the gut barrier and remodeling the gut microbiota in ApoE(-\/-) mice. Food Funct. 2021;12(16):7298\u2013309.","journal-title":"Food Funct"},{"issue":"1","key":"10768_CR223","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12986-022-00722-z","volume":"20","author":"X Xue","year":"2023","unstructured":"Xue X, et al. Gastrodin ameliorates atherosclerosis by inhibiting foam cells formation and inflammation through down-regulating NF-kappaB pathway. Nutr Metab Lond. 2023;20(1):9.","journal-title":"Nutr Metab Lond"},{"issue":"9","key":"10768_CR224","doi-asserted-by":"publisher","first-page":"e108577","DOI":"10.1371\/journal.pone.0108577","volume":"9","author":"SS Ghosh","year":"2014","unstructured":"Ghosh SS, et al. Oral supplementation with non-absorbable antibiotics or curcumin attenuates western diet-induced atherosclerosis and glucose intolerance in LDLR-\/- mice\u2013role of intestinal permeability and macrophage activation. PLoS One. 2014;9(9):e108577.","journal-title":"PLoS One"},{"key":"10768_CR225","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2021.114207","volume":"278","author":"Y Li","year":"2021","unstructured":"Li Y, et al. Mechanisms of traditional Chinese medicine in modulating gut microbiota metabolites-mediated lipid metabolism. J Ethnopharmacol. 2021;278:114207.","journal-title":"J Ethnopharmacol"},{"key":"10768_CR226","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph17207618","author":"Z Al Bander","year":"2020","unstructured":"Al Bander Z, et al. The gut microbiota and inflammation: an overview. Int J Environ Res Public Health. 2020. https:\/\/doi.org\/10.3390\/ijerph17207618.","journal-title":"Int J Environ Res Public Health"},{"key":"10768_CR227","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.546589","volume":"11","author":"W Ji","year":"2020","unstructured":"Ji W, et al. The enhanced pharmacological effects of modified traditional Chinese medicine in attenuation of atherosclerosis is driven by modulation of gut microbiota. Front Pharmacol. 2020;11:546589.","journal-title":"Front Pharmacol"},{"issue":"9","key":"10768_CR228","doi-asserted-by":"publisher","first-page":"e2105021","DOI":"10.1002\/smll.202105021","volume":"18","author":"XL Li","year":"2022","unstructured":"Li XL, et al. Bicyclol alleviates atherosclerosis by manipulating gut microbiota. Small. 2022;18(9):e2105021.","journal-title":"Small"},{"issue":"12","key":"10768_CR229","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1161\/CIRCRESAHA.117.312509","volume":"122","author":"C Cochain","year":"2018","unstructured":"Cochain C, et al. Single-cell RNA-Seq reveals the transcriptional landscape and heterogeneity of aortic macrophages in murine atherosclerosis. Circ Res. 2018;122(12):1661\u201374.","journal-title":"Circ Res"},{"key":"10768_CR230","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2023.1176267","volume":"10","author":"M Wu","year":"2023","unstructured":"Wu M, et al. Single-cell RNA-seq uncovers distinct pathways and genes in endothelial cells during atherosclerosis progression. Front Mol Biosci. 2023;10:1176267.","journal-title":"Front Mol Biosci"},{"issue":"11","key":"10768_CR231","doi-asserted-by":"publisher","first-page":"e264","DOI":"10.1161\/ATVBAHA.123.320330","volume":"44","author":"MG Gastanadui","year":"2024","unstructured":"Gastanadui MG, et al. Spatial transcriptomic approach to understanding coronary atherosclerotic plaque stability. Arterioscler Thromb Vasc Biol. 2024;44(11):e264\u201376.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"10768_CR232","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12964-023-01464-y","volume":"22","author":"HT Yang","year":"2024","unstructured":"Yang HT, et al. Faecalibacterium prausnitzii as a potential antiatherosclerotic microbe. Cell Commun Signal. 2024;22(1):54.","journal-title":"Cell Commun Signal"},{"key":"10768_CR233","doi-asserted-by":"publisher","DOI":"10.3390\/nu12030605","author":"E Sanchez-Rodriguez","year":"2020","unstructured":"Sanchez-Rodriguez E, et al. The gut microbiota and its implication in the development of atherosclerosis and related cardiovascular diseases. Nutrients. 2020. https:\/\/doi.org\/10.3390\/nu12030605.","journal-title":"Nutrients"},{"key":"10768_CR234","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.coph.2019.04.008","volume":"49","author":"FE Dailey","year":"2019","unstructured":"Dailey FE, et al. The dirty aspects of fecal microbiota transplantation: a review of its adverse effects and complications. Curr Opin Pharmacol. 2019;49:29\u201333.","journal-title":"Curr Opin Pharmacol"},{"key":"10768_CR235","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1146\/annurev-food-032818-121303","volume":"10","author":"Y Wu","year":"2019","unstructured":"Wu Y, et al. Interactions between food and gut microbiota: impact on human health. Annu Rev Food Sci Technol. 2019;10:389\u2013408.","journal-title":"Annu Rev Food Sci Technol"},{"key":"10768_CR236","doi-asserted-by":"publisher","first-page":"1153952","DOI":"10.3389\/fmicb.2023.1153952","volume":"14","author":"H Fujita","year":"2023","unstructured":"Fujita H, et al. Facilitative interaction networks in experimental microbial community dynamics. Front Microbiol. 2023;14:1153952.","journal-title":"Front Microbiol"},{"key":"10768_CR237","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2022.108991","volume":"105","author":"L Anto","year":"2022","unstructured":"Anto L, Blesso CN. Interplay between diet, the gut microbiome, and atherosclerosis: role of dysbiosis and microbial metabolites on inflammation and disordered lipid metabolism. J Nutr Biochem. 2022;105:108991.","journal-title":"J Nutr Biochem"},{"key":"10768_CR238","doi-asserted-by":"crossref","unstructured":"Russell BJ, et al. Intestinal transgene delivery with native chassis allows persistent physiological changes. Cell. 2022;185(17):3263-+.","DOI":"10.1016\/j.cell.2022.06.050"},{"key":"10768_CR239","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.1059349","volume":"12","author":"B Qian","year":"2022","unstructured":"Qian B, et al. Update on gut microbiota in cardiovascular diseases. Frontiers in Cellular and Infection Microbiology. 2022;12:1059349.","journal-title":"Frontiers in Cellular and Infection Microbiology"}],"container-title":["Journal of Cardiovascular Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12265-026-10768-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12265-026-10768-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12265-026-10768-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T16:02:39Z","timestamp":1776268959000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12265-026-10768-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,15]]},"references-count":239,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["10768"],"URL":"https:\/\/doi.org\/10.1007\/s12265-026-10768-6","relation":{},"ISSN":["1937-5387","1937-5395"],"issn-type":[{"value":"1937-5387","type":"print"},{"value":"1937-5395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,15]]},"assertion":[{"value":"16 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"All the authors read the final version and agreed to publish it.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent\u00a0for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent Statement"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional Review Board Statement"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"48"}}